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ABSTRACT
Introduction. We evaluated the knowledge of non-steroidal anti-
inflammatory drugs (NSAIDs) including their dosage, side effects, 
contraindications, and drug interactions among the patients in an 
outpatient rheumatology clinic.
Methods. Patients in a rheumatology clinic completed a short survey 
assessing their knowledge of over-the-counter NSAIDs.
Results. The survey was provided to 400 participants and 275 
(68.5%) were using over-the-counter (OTC) NSAIDs. The majority 
of the participants identified their commonly used NSAID. Almost a 
third were unaware of the contraindication of NSAIDs such as peptic 
ulcer disease, chronic kidney disease, and hypertension. Nearly 53.9% 
participants denied having any discussion of OTC medications with 
their providers. Two-thirds of the respondents reported seeing only 
the medication packaging for the dose determination (67.8%).
Conclusions. The gap in patient knowledge of the potential side 
effects and the lack of discussion of OTC medications by the provid-
ers may be predisposing the patients to preventable side effects from 
NSAIDs. Kans J Med 2019;12(4):132-135.
INTRODUCTION
In 1897, Felix Hoffman synthesized acetylsalicylic acid (ASA) and 
the first non-steroidal anti-inflammatory drug (NSAID) was discov-
ered.1 NSAIDs are among the most commonly used medications 
owing to their anti-pyretic, anti-inflammatory, and analgesic prop-
erties.2 Due to their easy availability, more than 30 million people 
worldwide use NSAIDs every day. NSAIDs account for almost 60% 
of the over-the-counter (OTC) analgesic market in the United States. 
OTC medications are used commonly in the adult population for 
analgesic effects.
NSAIDs are considered as relatively safe medications by the 
general population given their easy availability and having over-the-
counter status.3 However, they come with a broad spectrum of side 
effects. Side effects of NSAIDs usually are related to the inhibition 
of prostaglandins and thromboxane A-2. They involve many organ 
systems including gastrointestinal (GI), renal, and vascular systems. 
They can lead to gastric and duodenal ulceration by altering the 
mucosal integrity of the gastrointestinal tract, as well as worsening of 
hypertension and congestive heart failure. Other side effects include 
acute and chronic renal toxicity.
Up to 40% of NSAIDs users have GI side effects including reflux 
and dyspepsia.4 About 30 - 50% of users have endoscopic lesions of 
subepithelial hemorrhages, erosions, and ulcerations. In the kidneys, 
NSAIDs lead to reduced plasma flow and disrupt the compensatory 
vasodilation at the glomerular level by inhibiting renal prostaglan-
dins.5 NSAIDs also cause acute interstitial nephritis (AIN) in the 
kidney, characterized by the presence of inflammatory infiltrate 
in the renal interstitium. AIN accounts for about 15% of the unex-
plained causes of acute kidney injury. 
The effect of NSAIDs on the systolic blood pressure and increas-
ing the overall mortality among the patients with coronary artery 
disease also has been studied in randomized trials. Bavry et al.6 fol-
lowed chronic versus non-chronic NSAID users and found that, at the 
mean follow-up of 2.7 years, the primary outcome of all-cause mor-
tality, nonfatal myocardial infarction, and non-fatal stroke occurred 
at a rate of 4.4 events/100 patient-years in chronic NSAID users 
versus 3.7 events/100 patient-years in non-chronic NSAID users 
(95% CI 1.19 - 1.82, p = 0.0003). The study also reported an increase 
in cardiovascular mortality in the chronic NSAID user group (95% 
CI 1.70 - 3.01, p ≤ 0.0001).
Patients in rheumatology clinics commonly suffer from joint pain 
and stiffness and widely use OTC NSAIDs for symptomatic manage-
ment due to their anti-inflammatory and analgesic effects.7 However, 
the knowledge of the medication dosage and the potential side effects 
along with drug interactions is poor among the majority of the patient 
population. Mullan et al.8 found about one-third of their study par-
ticipants could not identify the maximal daily dose and were unaware 
of drug contraindications. Less than half of the study participants 
recognized the potential side effects of the NSAIDs. 
Cham et al.9 conducted a study of patients in the emergency depart-
ment and the patients were asked about the use of OTC medications. 
Of 213 patients, 143 admitted using NSAIDs. Female patients were 
more aware of the drug side effects. The use of ibuprofen was greater 
among the younger population and in patients with no primary care 
physician. Green et al.10 surveyed 294 physiotherapists and found 
62.6% of the participants were incorrect or unsure about where 
and how to obtain most NSAIDs. Participants also demonstrated 
lack of thorough knowledge of the risks and contraindications of the 
NSAIDs.
In this study, we evaluated the knowledge of NSAIDs including 
their dosage, side effects, contraindications, and drug interactions 
among the patients coming to the outpatient rheumatology clinic of 
Carle Foundation Hospital, the main tertiary care center in the city 
of Urbana-Champaign, Illinois.
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METHODS
Following approval from the institutional review board committee, 
the study was conducted between April 2018 and December 2018. 
Patients, non-pregnant and aged 18 years and over, who presented to 
the rheumatology clinic for follow-up or as new patients during were 
invited to take part in the study. Participants were selected regardless 
of gender and race. Those who agreed to participate in the study and 
had a clear mental capacity to fill in the survey were included in the 
study. Individuals who did not read or speak English or were unable 
to complete the survey unassisted were excluded from the study. A 
consent form, in the form of a cover letter, explaining the study in 
brief was attached with the survey. The survey was anonymous and 
patients were informed that their decision to participate in the study 
or not would not affect the treatment provided. 
Volunteering patients were asked to complete a 10-minute, paper-
based survey. Completed surveys were collected by the clinic nurse. 
The survey included demographic questions related to age, gender, 
education, and household income. The survey also included ques-
tions developed by the authors:
1) Do you take any of the following medications? Multiple choice 
options included: ibuprofen, naproxen, or aspirin (other than 81 mg).
2) Do you know the side effects of these medications? If yes, par-
ticipants were asked to check the side effects from the following 
options: indigestion, headache, dizziness, drowsiness, fluid retention, 
kidney problems, and liver, heart/circulation problems. 
3) Have you ever discussed the side effects of oral NSAIDs with 
your doctor or pharmacist? And have you ever read the directions or 
warnings written on the medication bottle/box? Yes or No responses 
were required for these questions.
4) How do you determine the proper dose of over-the-counter 
medications? Patients were asked to check from the following 
options: pharmacist, consultation with their doctor, ask the nurse, 
see the back of the medication bottle, take it as needed without deter-
mining the dose. 
5) Do you have any of the following or have you ever had any of 
the following problems? Patients were asked to check the answers 
from the following choices: kidney problems (such as chronic kidney 
disease), asthma, high blood pressure, use of any blood thinners, 
history of heart disease (such as angina, coronary artery disease, 
chest pain with exertion), or stomach problems (such as peptic ulcer 
disease, gastritis, or history of GI bleed). 
6) Patient knowledge regarding over-the-counter medication was 
asked in the form of yes or no responses for the final four questions of 
the survey: oral NSAIDs can cause stomach problems such as heart-
burn and even stomach ulcers, over-the-counter pain medications 
can cause problems in the kidney including kidney failure, over-the-
counter pain medications can increase blood pressure and also can 
increase the risk of heart attacks and strokes, and over-the-counter 
pain medications have to be taken with meals. 
Sample size was calculated at 400 with the aim to have 95% confi-
dence interval to be about 5% and the actual percentages to be 50%. 
Statistical analysis software (SAS Version 9.4) was used to analyze 
the data.
RESULTS
Demographic Information and Health Literary Level. The 
average age of the eligible patients was 55.7 years (± 14.9). Females 
predominated (72.4%) compared to males (27.6%). Most partici-
pants were white (86.7%). A total of 61.2% of the participants had 
college or higher education. The majority (66.7%) had an annual 
income below $50,000. A total of 68.9% of the participants reported 
having used at least one OTC NSAID.
Use of OTC NSAIDs and Knowledge of the Potential Side 
Effects. Of 400 patients who participated in the study, 275 (68.9%) 
took OTC medications. Among the three NSAID options (ibuprofen, 
naproxen, and aspirin (other than 81 mg)), nearly two-thirds (69.3%, 
n = 190) responded they took ibuprofen. Other study participants 
reported taking naproxen (35.3%, n = 97) and aspirin (other than 
the 81 mg dosage; 16.7%, n = 46). Patients did not report taking any 
other OTC NSAIDs. The following study results focused on the 275 
NSAID users.
Over two-thirds (72.7%, n = 200) of the respondents taking OTC 
medications acknowledged being aware of their side effects. Partici-
pants were given the list of side effects caused by NSAIDs including 
indigestion, headache, dizziness, drowsiness, fluid retention, kidney 
problems, and liver or heart/circulation problems. A total of 62.3% 
(n = 170) of the patients indicated that they are aware of at least three 
side effects, 19.8% (n = 54) participants were aware of more than 
three side effects, and 18.0% (n = 49) did not have any knowledge of 
the side effects caused by the NSAIDs. 
Most participants (n = 236, 86.5%) agreed that NSAIDs can cause 
heartburn, less than half (n = 115, 42.4%) agreed that NSAIDs should 
be taken with meals, highlighting that 160 patients (or 57.6%) were 
unaware of taking NSAIDs with meals or on a full stomach. The study 
participants did well in relating NSAIDs as the potential cause of 
kidney failure (n = 218, 79.9%). Over half (n = 158, 57.9%) of the study 
participants who took the NSAIDs correctly answered when inquired 
about the association of NSAIDs and elevated blood pressure.
 A total of 53.9% of patients (n = 147) denied having any discus-
sion with their providers regarding the OTC NSAIDs they take, while 
46.2% of patients (n = 126) reported discussing these medications 
with their physician. The majority (77.7%, n = 212) of the respondents 
reported reading the directions and warnings on the medication 
bottle/box. Nearly two-thirds (64.8%, n = 177) of the respondents 
reported seeing only the bottle label for the dose determination. A 
total of 22.1% (n = 60) consulted the doctor regarding the dose of 
OTC NSAIDs and 13.6% (n = 37) asked their local pharmacist. There 
was 12.9% (n = 35) of the respondents who reported taking OTC 
NSAIDs without dose determination and consultation. 
Existing Co-Morbidities in the Patient Population. A total of 
27.9% (n = 76) of respondents reported having gastric problems such 
as history of peptic ulcer disease, gastritis, or GI bleed. About one-
fourth of respondents reported a history of asthma (26.4%, n = 72). 
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= 71), whereas 12.5% (n = 34) reported having a history of chronic 
kidney disease and 11% (n = 30) had a history of coronary artery 
disease. Nearly two-thirds (44.3%, n = 121) reported having only one 
comorbidity. 
Logistic Regression Results. “Aware of side effects” was the 
primary outcome for assessing the understanding of participants 
regarding side effects of OTC NSAIDs. After univariate analysis, con-
trolling for age and gender, patients with more income (≥ $35,000 
-$49,000 and ≥ $50,000) were significantly (adjusted OR 2.6 95% 
CI: 1.2, 5.7; adjusted OR 2.7 95% CI: 1.3, 5.5 respectively) more aware 
of the side effects of the OTC NSAIDS. No significant association 
between level of education and knowledge of side effects of NSAIDS 
was found. Females were almost three times (OR: 2.8 95% CI: (1.5, 
5.2) more likely to read the warnings regarding over dosage as com-
pared to males.
DISCUSSION
NSAIDs are one of the oldest, most accessible, and most commonly 
used medications. Scientific advances have made healthcare provid-
ers aware of the numerous side effects of these medications, however, 
the discussion of the side effects of OTC NSAIDs with the patient 
population is not very frequent.11 Ridout et al.11 reported that out of 
443 patients who participated in their survey, 275 respondents (62%) 
felt that the medication dosing and the side effects were not explained 
in detail by their providers or pharmacists. To specify the medications 
further, Wynne et al.12 studied the intake of OTC NSAIDs versus the 
knowledge of the side effects in their patient population. The study 
found that patients who were not informed about the adverse effects 
of NSAIDs by their providers were less likely to reduce the intake of 
these medications in response to epigastric pain. A total of 36% of 
patients who suffered from GI bleed had a prior experience of epi-
gastric discomfort, and only 11% admitted reduced compliance with 
the NSAID therapy when they were not informed about the adverse 
effects compared with the controls.
In 2005, a study among the patients suffering from osteoarthri-
tis was conducted regarding their awareness of the side effects of 
NSAIDs.13 A total of 3,755 patients were surveyed and 35.5% of the 
patients were aware of the side effects of non-steroidal anti-inflam-
matory medications.
The results from our study highlighted the need for patient edu-
cation regarding the side effects of OTC NSAIDs. Our observation 
indicated that OTC NSAIDs are used more frequently by the mid-
dle-aged patients and that women are more frequent consumers of 
NSAIDs, which is in line with similar studies.14 
Our findings supported a cross sectional study by Cullen et al.15 
in which the patients were inquired about the adverse reactions to 
the common medications. Patients underrated the risk of adverse 
events and considered NSAIDs as low-risk medications with the 
lack of knowledge of the upper GI bleeding as a potential side effect. 
Ngo et al.16 also reported the lack of knowledge among their patient 
population regarding the potential serious adverse effects of non-pre-
scription analgesics such as ibuprofen. This study further highlighted 
that 66% of the study participants (n = 110) reported rarely or never 
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reading manufacturer’s printed warning instructions at the back of 
the medication packaging.
The relationship of exceeding the labeled maximum daily dose of 
medication has been linked with the patients’ health literacy level. 
Kaufman et al.17 identified the relationship of low health literacy 
scores (measured by the Rapid Estimate of Adult Literacy in Medi-
cine) with the excessive intake of acetaminophen among patients. 
The gap in knowledge of the adverse reactions from OTC NSAIDs 
and the lack of discussion of OTC medications in the provider’s office 
can predispose the patient to avoidable complications such as GI 
bleed, acute kidney injury, and hypertension.18 The lack of knowledge 
of the dosing and the side effects of the easily available OTC medica-
tions highlight a serious public health issue that should be discussed 
among the healthcare providers.
In our clinic, physicians often provide reconciliation of prescribed 
medications for pain control, but it is seldom seen that the patients 
are inquired about their use of OTC medications and whether they 
are aware of the adverse reactions. The responsibility lies more on 
the physicians than the pharmacists as most of the NSAIDs are easily 
available outside the pharmacy.  
Our study highlighted an urgent need for the discussion of OTC 
pain medications between the patients and their healthcare provid-
ers. The discussion should not be limited to rheumatology clinics, but 
also should take place with the primary care provider. Patients in our 
study relied on the product label for the dose determination of OTC 
medications. However, the maximum allowed dose can vary among 
patients depending on co-existing comorbidities such as chronic 
renal or heart failure, hypertension, and history of GI bleed. There-
fore, discussion between the providers and patients is encouraged. It 
should provide encouragement to the patients to discuss these medi-
cations openly in their follow-up visits and may limit excessive intake 
of such medications. Furthermore, there is a need to identify if the 
information on the medication packaging is comprehensible for the 
patients with low health literacy.
Limitations. This study was limited in several areas. Partici-
pants were not asked the reason for using OTC medications and the 
maximum number of tablets they consume every day. Also, the inter-
val between the tablets was not asked. The generalizability of our 
study findings are limited by the fact that the study was conducted 
in one rheumatology clinic and participants from culturally and lin-
guistic diverse backgrounds were unable to complete the survey due 
to language barriers.
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CONCLUSIONS
This study highlighted that the patients using OTC analgesics 
have gaps in their knowledge of the side effects and the dosing of 
these medications. Patients often rely on the medication packaging 
for information of the maximum dosage and do not discuss taking 
those medications with their physicians. Such practices can predis-
pose the patients to several preventable adverse reactions. This is a 
public health issue that needs to be addressed in outpatient primary 
care clinics through proper education of both providers and patients 
to allow open communication regarding all OTC medications, espe-
cially those with high side effect profile such as NSAIDs.
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